IDEX Corporation — FY2016 Form 10-K
Reporting period: Fiscal year ended December 31, 2016. This is an annual filing, not a standalone fourth-quarter report; fourth-quarter figures are noted separately below. IDEX supplies pumps, valves, flow meters, precision fluidics and optics, fire-and-rescue products, and other engineered products through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). Approximately 50% of 2016 sales were to customers outside the United States.
Financial results and liquidity
| Metric | FY2016 | FY2015 |
|---|---|---|
| Net sales | $2,113.0 million | $2,020.7 million |
| Gross profit / margin | $930.8 million / 44.0% | $904.3 million / 44.8% |
| Operating income / margin | $405.8 million / 19.2% | $431.7 million / 21.4% |
| Net income | $271.1 million | $282.8 million |
| Diluted EPS | $3.53 | $3.62 |
| Cash from operating activities | $399.9 million | $360.3 million |
| Capital expenditures | $38.2 million | $43.8 million |
| Cash and cash equivalents at year-end | $236.0 million | $328.0 million |
| Total borrowings at year-end | $1,020.9 million | $847.4 million |
Working capital was $513.6 million and the current ratio was 2.66. Of year-end cash, $190.3 million was held outside the U.S. The $700 million revolving credit facility had $169.6 million drawn and $521.2 million of net available capacity. IDEX reported compliance with its debt covenants: leverage ratio 1.91x against a 3.50x maximum and interest coverage 11.51x against a 3.0x minimum. The annual dividend was $1.36 per share.
Management’s adjusted, non-GAAP measures were adjusted operating income of $435.3 million (20.6% margin), adjusted net income of $288.4 million, adjusted EPS of $3.75, and adjusted EBITDA of $530.5 million (25.1% margin). These exclude specified items and should be considered alongside GAAP results.
Material changes and segment performance
- Sales rose 5%, but organic sales declined 1%; acquisitions/divestitures contributed a net 7% and foreign exchange reduced sales by 1%.
- FMT sales declined 1% to $849.1 million; operating income increased 5% to $214.2 million and margin improved 140 basis points to 25.2%.
- HST sales increased 1% to $744.8 million; operating income declined 3% to $153.7 million and margin declined 80 basis points to 20.6%.
- FSDP sales increased 23% to $520.0 million, mainly from acquisitions; operating income rose 5% to $121.9 million, while margin fell 390 basis points to 23.4%.
- FY operating income and GAAP EPS declined despite higher sales. Results included a $22.3 million net loss on business sales, a $3.6 million pension settlement charge, and $14.7 million of acquisition-related inventory step-up charges. The prior year included an $18.1 million gain on sale.
- Quarterly comparison: Q4 2016 sales were $530.4 million versus $499.8 million in Q4 2015; operating income was $81.4 million versus $98.3 million, net income $57.3 million versus $67.8 million, and diluted EPS $0.75 versus $0.88.
Outlook, risks, and unusual items
- Management projected 1%–2% organic growth in 2017 and full-year EPS of $3.87–$3.95, while citing uncertainty in global economic and political conditions.
- 2016 acquisitions included Akron Brass, AWG Fittings, and SFC Koenig, for total cash consideration of approximately $510 million. The company also completed four divestitures and recognized the net disposal loss noted above.
- Key risks include economic and industrial-market weakness, low order backlogs, oil and other commodity-price volatility, foreign exchange and interest-rate changes, competitive pricing, acquisition integration and execution, cybersecurity, and potential impairment of goodwill or intangible assets. Goodwill was $1.63 billion and intangible assets were $435.5 million at year-end; impairment testing found reporting-unit fair values above carrying values.
- Asbestos-related personal-injury lawsuits remain pending. Most resolved claims were dismissed without payment, and settlements and most legal costs to date were largely covered by insurance, subject to deductibles. The company made no provision beyond ordinary-course insurance deductibles and did not expect a material adverse effect; future insurance coverage is uncertain. Other ordinary-course proceedings were not expected to be material.
- Undistributed foreign-subsidiary earnings were $670 million; additional U.S. tax could be material if repatriated. The company also disclosed pension and post-retirement obligations, and sensitivity of pension obligations to discount-rate assumptions.
Investor verification checklist
- Review the bridge from 5% reported sales growth to the 1% organic decline, including acquisition, divestiture, and currency effects.
- Assess whether the 2017 organic-growth and EPS outlook was achieved, and how much future growth depends on acquisitions versus underlying demand.
- Track segment margins, particularly FSDP and HST, and the effects of acquisition integration and purchase-accounting charges.
- Confirm debt, interest costs, covenant headroom, and the use of cash and revolving capacity for acquisitions, dividends, and share repurchases.
- Monitor goodwill and intangible-asset valuations, pension funding assumptions, tax exposure related to foreign earnings, and insurance coverage for asbestos claims.
The independent auditor issued an unqualified opinion on the consolidated financial statements. Management and the auditor reported effective internal control over financial reporting; the three 2016 acquisitions were excluded from the internal-control assessment due to acquisition timing.